• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限于器官内、不可触及的移行带大前列腺癌:与前列腺特异性抗原转移水平的关联

Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.

作者信息

Stamey T A, Dietrick D D, Issa M M

机构信息

Department of Urology, Stanford University School of Medicine, California.

出版信息

J Urol. 1993 Mar;149(3):510-5. doi: 10.1016/s0022-5347(17)36131-1.

DOI:10.1016/s0022-5347(17)36131-1
PMID:7679754
Abstract

We present 3 of 25 patients with massive, occult transition zone cancers 7 to 86 cc in volume. Despite serum prostate specific antigen (PSA) levels of 150 to 456 ng./ml. (Yang polyclonal assay), all 3 were organ confined at radical prostatectomy and have undetectable serum PSA levels by an ultrasensitive assay at 300 to 650 days postoperatively. This clinical syndrome includes a highly elevated PSA level, benign prostatic hyperplasia on digital rectal examination, a nondiagnostic transrectal ultrasound and frequently negative transrectal or perineal needle biopsies. Clinical recognition of this syndrome plus systematic biopsies of the transition zone are the keys to diagnosis and potential cure of these patients. These cases may explain the 10% rate of men who present with metastatic prostate cancer and a normal rectal examination, much of the discrepancy between focal cancer on biopsy and large cancers in radical prostatectomy specimens, and why some men have an extraordinarily high serum PSA level and organ-confined cancer at prostatectomy.

摘要

我们报告了25例体积为7至86立方厘米的隐匿性移行区大癌患者中的3例。尽管血清前列腺特异性抗原(PSA)水平为150至456纳克/毫升(杨的多克隆检测法),但这3例患者在根治性前列腺切除术中均局限于器官内,且术后300至650天通过超敏检测法检测不到血清PSA水平。这种临床综合征包括PSA水平高度升高、直肠指检显示良性前列腺增生、经直肠超声检查无诊断意义以及经直肠或会阴穿刺活检经常为阴性。对该综合征的临床认识以及对移行区进行系统活检是诊断和治愈这些患者的关键。这些病例可能解释了10%出现转移性前列腺癌且直肠检查正常的男性比例、活检中局灶性癌与根治性前列腺切除标本中较大癌之间的许多差异,以及为什么一些男性血清PSA水平极高且在前列腺切除术中为器官局限性癌。

相似文献

1
Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.局限于器官内、不可触及的移行带大前列腺癌:与前列腺特异性抗原转移水平的关联
J Urol. 1993 Mar;149(3):510-5. doi: 10.1016/s0022-5347(17)36131-1.
2
An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.148例连续性移行区癌的分析:临床及组织学特征
J Urol. 2000 Jun;163(6):1751-5.
3
Prostate cancer screening in Tyrol, Austria: experience and results.奥地利蒂罗尔州的前列腺癌筛查:经验与结果
Eur Urol. 1999;35(5-6):523-38. doi: 10.1159/000019893.
4
[Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
Arch Ital Urol Androl. 1997 Dec;69(5):313-8.
5
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.术前血清前列腺特异性抗原水平在2至22纳克/毫升之间与根治性前列腺切除术后的癌症形态相关性较差:前列腺特异性抗原治愈率在2至9纳克/毫升之间似乎保持不变。
J Urol. 2002 Jan;167(1):103-11.
6
The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.土耳其男性中游离前列腺特异性抗原百分比、整个前列腺及移行带的前列腺特异性抗原密度的价值。
Can J Urol. 2000 Oct;7(5):1104-9.
7
Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL.血清前列腺特异性抗原水平在 2.5 至 4.0ng/ml 之间的韩国男性人群中不可触及前列腺癌的检出率。
Urology. 2010 Oct;76(4):919-22. doi: 10.1016/j.urology.2009.12.036. Epub 2010 Mar 29.
8
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.重复前列腺穿刺活检中前列腺癌的最佳预测指标:一项针对1051名男性的前瞻性研究
J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.
9
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml].血清前列腺特异性抗原水平在4至10 ng/ml之间的有症状患者中前列腺癌的检测
Presse Med. 1996 Feb 24;25(7):272-6.
10
Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.血清前列腺特异性抗原水平与前列腺穿刺活检结果的相关性
Bull Cancer. 2016 Sep;103(9):730-4. doi: 10.1016/j.bulcan.2016.05.006. Epub 2016 Jun 23.

引用本文的文献

1
Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights.磁共振成像检测到前列腺隐匿性前部肿瘤:进一步见解
Can Urol Assoc J. 2015 May-Jun;9(5-6):E267-72. doi: 10.5489/cuaj.2562.
2
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.MRI 测算的前列腺体积与经体积校正的血清前列腺特异性抗原:与前列腺癌 Gleason 评分的相关性。
AJR Am J Roentgenol. 2013 Nov;201(5):1041-8. doi: 10.2214/AJR.13.10591.
3
Novel diagnostic biomarkers for prostate cancer.
用于前列腺癌的新型诊断生物标志物。
J Cancer. 2010 Oct 6;1:150-77. doi: 10.7150/jca.1.150.
4
Prognostic significance of prostate cancer originating from the transition zone.起源于移行带的前列腺癌的预后意义。
Urol Oncol. 2009 Nov-Dec;27(6):592-7. doi: 10.1016/j.urolonc.2008.05.009. Epub 2008 Sep 16.
5
Giant organ confined prostatic adenocarcinoma: a case report.巨大器官局限性前列腺腺癌:一例报告
J Med Case Rep. 2008 Jan 29;2:28. doi: 10.1186/1752-1947-2-28.
6
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.p501s(prostein)在检测转移性前列腺腺癌方面与前列腺特异性抗原(PSA)的诊断效用比较。
Diagn Pathol. 2007 Oct 27;2:41. doi: 10.1186/1746-1596-2-41.
7
[Transrectal ultrasound of the prostate. Current status and prospects].[经直肠前列腺超声检查。现状与展望]
Urologe A. 2002 Nov;41(6):559-68. doi: 10.1007/s00120-002-0245-8.
8
The role of transrectal ultrasound in diagnosing prostate cancer.
Curr Urol Rep. 2002 Jun;3(3):194-200. doi: 10.1007/s11934-002-0064-x.
9
Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.全科医生与泌尿科医生在良性前列腺增生管理中的共同照护:临床医生态度调查
J R Soc Med. 1995 May;88(5):284P-288P.
10
Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.前列腺疾病:基层医疗团队的管理方案。英国前列腺组织工作小组报告。
Postgrad Med J. 1995 Mar;71(833):136-42. doi: 10.1136/pgmj.71.833.136.